NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma

被引:12
作者
Liu, Rongqiang [1 ,2 ,3 ]
Li, Rongqi [4 ]
Yu, Haoyuan [1 ,2 ]
Liu, Jianrong [5 ]
Zheng, Shiyang [6 ]
Li, Yang [1 ,2 ]
Ye, Linsen [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou, Peoples R China
[4] Foshan Hosp Tradit Chinese Med, Dept Hepatobiliary Surg, Foshan, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 3, Surg & Transplant Intens Care Unit, Guangzhou, Peoples R China
[6] Guangzhou Med Univ, Affiliated Hosp 3, Dept Breast Surg, Guangzhou, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
NTF3; hepatocellular carcinoma; prognosis; immune infiltrates; TGCA; REGULATORY T-CELLS; GENE-EXPRESSION; CORE BIOPSY; CANCER; THERAPY; TARGET; NEEDLE; ATR;
D O I
10.3389/fmed.2021.795849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The potential role of Neurotrophic factor-3(NTF3) in liver cancer is unknown. Therefore, we aimed to explore the clinical value of NTF3 in hepatocellular carcinoma (HCC).Methods: We used a variety of databases to analyze the expression, relationship with prognosis and immune significance of NTF3 in liver cancer through bioinformatics.Results: NTF3 was low expressed in HCC and was an independent prognostic factor in patients with HCC. CIBERSORT analysis indicated that NTF3 expression was positively correlated with CD4+ cells, mast cells, NK cells, macrophages and B cells in the tumor microenvironment. Furthermore, we found that NTF3 expression was negatively correlated with the immune checkpoints PD-L1, TIGIT and TIM-3. Functional network analysis revealed that NTF3 regulates HCC progression through a variety of cancer-related kinases, transcription factors and signaling pathways.Conclusions: We demonstrate that NTF3 correlates with prognosis and immune infiltration in HCC.
引用
收藏
页数:13
相关论文
共 45 条
[11]   Tolerance Induced by Apoptotic Antigen-Coupled Leukocytes Is Induced by PD-L1+ and IL-10-Producing Splenic Macrophages and Maintained by T Regulatory Cells [J].
Getts, Daniel R. ;
Turley, Danielle M. ;
Smith, Cassandra E. ;
Harp, Christopher T. ;
McCarthy, Derrick ;
Feeney, Emma M. ;
Getts, Meghann Teague ;
Martin, Aaron J. ;
Luo, Xunrong ;
Terry, Rachael L. ;
King, Nicholas J. C. ;
Miller, Stephen D. .
JOURNAL OF IMMUNOLOGY, 2011, 187 (05) :2405-2417
[12]   The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression [J].
Ghiringhelli, Francois ;
Menard, Cedric ;
Martin, Francois ;
Zitvogel, Laurence .
IMMUNOLOGICAL REVIEWS, 2006, 214 :229-238
[13]   Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+CD25+Foxp3+regulatory T cells in the immune microenvironment [J].
Granito, Alessandro ;
Muratori, Luigi ;
Lalanne, Claudine ;
Quarneti, Chiara ;
Ferri, Silvia ;
Guidi, Marcello ;
Lenzi, Marco ;
Muratori, Paolo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (22) :2994-3009
[14]   YY1 regulates cancer cell immune resistance by modulating PD-L1 expression [J].
Hays, Emily ;
Bonavida, Benjamin .
DRUG RESISTANCE UPDATES, 2019, 43 :10-28
[15]   A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells [J].
Hoechst, Bastian ;
Ormandy, Lars A. ;
Ballmaier, Matthias ;
Lehner, Frank ;
Krueger, Christine ;
Manns, Michael P. ;
Greten, Tim F. ;
Korangy, Firouzeh .
GASTROENTEROLOGY, 2008, 135 (01) :234-243
[16]   TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM [J].
Hung, Alice L. ;
Maxwell, Russell ;
Theodros, Debebe ;
Belcaid, Zineb ;
Mathios, Dimitrios ;
Luksik, Andrew S. ;
Kim, Eileen ;
Wu, Adela ;
Xia, Yuanxuan ;
Garzon-Muvdi, Tomas ;
Jackson, Christopher ;
Ye, Xiaobu ;
Tyler, Betty ;
Selby, Mark ;
Korman, Alan ;
Barnhart, Bryan ;
Park, Su-Myeong ;
Youn, Je-In ;
Chowdhury, Tamrin ;
Park, Chul-Kee ;
Brem, Henry ;
Pardoll, Drew M. ;
Lim, Michael .
ONCOIMMUNOLOGY, 2018, 7 (08)
[17]   Therapy in Advanced Hepatocellular Carcinoma [J].
Javan, Hanna ;
Dayyani, Farshid ;
Abi-Jaoudeh, Nadine .
SEMINARS IN INTERVENTIONAL RADIOLOGY, 2020, 37 (05) :466-474
[18]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
[19]   The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function [J].
Johnston, Robert J. ;
Comps-Agrar, Laetitia ;
Hackney, Jason ;
Yu, Xin ;
Huseni, Mahrukh ;
Yang, Yagai ;
Park, Summer ;
Javina, Vincent ;
Chiu, Henry ;
Irving, Bryan ;
Eaton, Dan L. ;
Grogan, Jane L. .
CANCER CELL, 2014, 26 (06) :923-937
[20]   Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer [J].
Kawakami, Masanori ;
Mustachio, Lisa Maria ;
Rodriguez-Canales, Jaime ;
Mino, Barbara ;
Roszik, Jason ;
Tong, Pan ;
Wang, Jing ;
Lee, J. Jack ;
Myung, Ja Hye ;
Heymach, John V. ;
Johnson, Faye M. ;
Hong, Seungpyo ;
Zheng, Lin ;
Hu, Shanhu ;
Villalobos, Pamela Andrea ;
Behrens, Carmen ;
Wistuba, Ignacio ;
Freemantle, Sarah ;
Liu, Xi ;
Dmitrovsky, Ethan .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (06)